Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Further DRPs were classified as ADR (n = 41), needs additional drug therapy (n = 37), transition error, (n = 26), interactions (n = 23), dosage too low (n = 14), monitoring need (n = 13) and noncompliance (n = 4) (Table 2).Clinically relevant DRPs identified by clinical pharmacists and discussed with the health care teamType of DRPsIdentified problem/potential problemIdentified no. of DRPs (no. acted upon)Drugs involved (frequency)Suspected adverse drug reaction (n = 41)Acute renal failure1 (1)IrbesartanAnemia1 (0)Acetylsalicylic acidConfusion3 (3)Metoprolol, morphine, solifenacinFall7 (5)Alfuzosin, candesartan, citalopram, mirtazapine, oxazepam, zopiclone (2)Fatigue5 (4)Mianserin, morphine (2), olanzapine, propiomazineHallucinations1 (1)CitalopramHypercalcemia1 (1)BendroflumethiazideHyperkalemia1 (1)SpironolactoneHypochloremia, high CO2 1 (1)FurosemideHypokalemia1 (1)FurosemideHyponatremia2 (1)Buspirone, losartanHypotension2 (2)Alfuzosin (2)Increased INR1 (0)AvlosulfonLiver disorder2 (2)Simvastatin (2)Nausea4 (3)Codeine/acetaminophen, galantamine, levetiracetam, metforminEdema1 (1)AmlodipineOrthostatic hypotension2 (1)Bendroflumethiazide, isosorbide mononitrateSeizure1 (0)DonepezilSleeping problems1 (1)BisoprololThrombocytopenia1 (1)Valproic acidUrinary retention2 (2)Amitriptyline, citalopramDosage too high (44)Dosage too high according to indication/guidelines18 (15)Acetylsalicylic acid (5), allopurinol, citalopram (2), folic acid (4), metoclopramide, omeprazole, risperidone, trihexyphenidyla (2), zuclopenthixolDosage too high according to patient response10 (8)Bisoprolol, clomethiazole, furosemide (2), isosorbide mononitrate, levothyroxine (2), mirtazapine, potassium, spironolactoneDosage too high according to liver function1 (1)AcetaminophenDosage too high according to renal function12 (12)Allopurinol, digoxin (3), enalapril, fondaparinux, glipizide, memantine (3), metformin, sucralfateDosage too high according to maximum dose per day2 (2)Acetaminophen (2)Lack of gradual dose increase1 (1)RivastigmineDosage too low (14)Dosage too low according to indication/guidelines14 (14)Acetylsalicylic acidb, amoxicillin (2), calcium (2), dalteparin, ferrous succinate, flucloxacillin, ipratropium, losartan, omeprazole (2), pivecillinam, sodium picosulfatec Ineffective/Inappropriate drug (54)Inappropriate drug according to cost4 (4)Escitalopram, oxycodone (2), pregabalinInappropriate drug according to renal function12 (12)Glibenclamide (2), hydrochlorothiazide, ibumetin, ketoprofen, metformin (2), morphine (2), nitrofurantoin, tramadol (2)Inappropriate drug according to liver function1 (1)ClomethiazoleInappropriate drug according to guidelines4 (3)Acetylsalicylic acid/dipyramidole, lactitol, methenamine hippurate, oxycodone + buprenorphineDrugs that should be avoided in the elderly17 (10)Amitriptyline, diazepam, fesoterodine, flunitrazepam, haloperidol, hydroxyzine, propiomazine (3), solifenacin, tolterodine (2), tramadol, triazolam, zolpidem (3)Heart failure6 (6)Acetaminophen soluble tablet qd, acetylcysteine soluble tablet qd, diclofenac, ibuprofen, naproxen, potassiumd Atrial fibrillation1 (0)PropranololHyperkalemia2 (2)Potassium IV (2)Hypertension4 (3)Acetaminophen soluble tablet qd (2), atenolol, pindololMyocardial infarction, past1 (1)Medroxyprogesterone acetatePalpitations1 (1)Metoprolol sustained-release tabletRisk in this specific patient group1 (0)Codeine/acetaminophen + acetaminophen PRNInteraction (23)Interactions23 (16)Alendronat + calciumCalcium + ciprofloxacinCarbamazepine + citalopramCarbamazepine + doxycyclinecholestyramine (PRN) + Warfarin + levothyroxine + furosemideDoxycycline + calciumFerrous glycine sulfate + levothyroxineFerrous glycine sulfate + levodopa/benserazideFerrous succinate + calcium + levothyroxineFerrous succinate + calcium (4)Ferrous succinate + ciprofloxacinFerrous succinate + levothyroxine (2)Levothyroxine + magnesium hydroxideLevothyroxine + magnesiumhydroxide + calciumWarfarin + diclofenac (2)Warfarin + ginkgo bilobaWarfarin + prednisoloneWarfarin + citalopramMonitoring need (13)Lack of liver function testse 1 (1)AcetaminophenLack of serum digoxin test1 (1)DigoxinLack of serum hemoglobin A1c test1 (1)Lack of serum homocysteine test1 (1)Vitamin B combinationLack of serum potassium test2 (2)Spironolactone (2)Lack of serum potassium and serum creatinine tests1 (1)Enalapril and spironolactoneLack of serum uric acid test1 (1)DiazoxideLack of thyroid function tests4 (4)Levothyroxine (4)Lack of thyroid function testsf 1 (1)Needs additional drug therapy/untreated/undertreated indication (37)Asthma1 (1)Short-acting inhaled beta-2-agonistHeart failure8 (6)ACE-inhibitor (4), beta-blocker (2), spironolactone (2)Hypertension1 (1)ACE-inhibitorHypokalemia1 (1)PotassiumIncreased risk of obstipation7 (5)Opioids without laxantia (7)Increased risk of ulcus5 (4)Clopidogrel, acetylsalicylic acid + galantamine without PPIPrednisolone + acetylsalicylic acid + donepezil without PPIPrednisolone + acetylsalicylic acid without PPIWarfarin + prednisolone without PPIPrevious ulcus, PPI discontinued by mistakeMyocardial infarction, past2 (0)Beta-blocker, acetylsalicylic acidOsteoporosis/vertebral compression fracture3 (2) 1 (1)Calcium/vitamin D3 (3)BisphosphonatePain1 (1)AcetaminophenSeizure1 (1)Gabapenting Stroke, past3 (2)Anticoagulant (3)Stroke, past1 (0)StatinTIA, past1 (1)AnticoagulantWernicke-Korsakoff syndrome1 (1)Vitamin B combinationNoncompliance (4)Handling problems: crushing1 (0)Doxazosin sustained-release tablet, hydroxycarbamide, metoprolol sustained-release tablet, morphine sustained-release tablet, omeprazoleh Handling problems: inhalation technique2 (2)Budesonide, terbutalineh Budesonide, indacaterol, terbutaline, tiotropiumh Overuse1 (0)HydroxyzineTransition error (26)Wrong dose or time of dose in the medical record11 (9)Citalopram, digoxin, hydralazine, mianserin(2), mirtazapine, pramipexole, risperidone, vitamin B, zolpidem, zopicloneDrug incorrectly registered in the medical record6 (6)Ciprofloxacin, fluconazoli, metformin, metoprolol, mianserin, simvastatinDrug is missing in the medical record8 (7)Acetaminophen (2), acetylsalicylic acid, bimatoprost/timolol, citalopram, ibuprofen, levothyroxine, memantine,Wrong information about the drug in the medical record1 (0)KetobemidoneUnnecessary drug therapy (54)No indication for drug use48 (41)Alendronat, allopurinol, amlodipine (2), bendroflumethiazide, carbamazepine, citalopram, clemastine, codeine/acetaminophen, cyanocobalamin/folic acid/pyridoxine hydrochloride, enalapril, ferrous succinate (2), folic acid, folic acid/cyanocobalamin (2), furosemide (5), gabapentin, haloperidol (2), ibumetin, loperamide, losartan, magnesium hydroxide (3), metformin (4), metoprolol, acetaminophen, potassium(4),prednisolone, probenecide, ranitidine, simvastatin, sodium hydrogen carbonate (2), zopiclone (2)Inappropriate duplication6 (6)Estradiol vaginal ring + estradiol vaginal tabletlactulose + macrogol/electrolytes (3)warfarin + acetylsalicylic acidj warfarin + clopidogrelk Abbreviations: DRP drug-related problem, LMWH low molecular weight heparin, PPI proton pump inhibitors, PRN Pro Re Nata, TIA transient ischemic attack aDose of antipsychotic lowered, but not trihexyphenidyl (Table 3) bThe patient had atrial fibrillation cPrescribed PRN dSpironolactone suggested eThe patient was overusing acetaminophen fThe patient had atrial fibrillation gGabapentine discontinued as doctors thought the indication was pain; really, it was epilepsy hClassified as one DRP iFluconazol in the category interaction (with citalopram) in Table 3 jWarfarin prescribed instead of acetylsalicylic acid, both treatments continued by mistake kWarfarin prescribed instead of clopidogrel, both treatments continued by mistake

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Eligible patients were aged 65 years or older and had dementia or cognitive impairment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Drug-related problems and medication reviews among old people with dementia

Study design awaiting verification · BMC Pharmacology & Toxicology · 2017

Original publication title

Drug-related problems and medication reviews among old people with dementia

Bettina Pfister; Jeanette Jonsson; Maria Gustafsson

© The Author(s). 2017

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Drug-related problems are common among people with dementia and cognitive impairment. Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Drug-related problems, including medication errors and adverse drug events, are common among old people. Due to, for example, greater susceptibility to side effects, people with dementia are even more at risk of drug-related problems. The objectives of this study were to assess the occurrence and character of drug-related problems found among old people with dementia or cognitive impairment.

Source: Background

Abstract: What methods does the paper describe?

Data from a randomized controlled clinical trial exploring the effects of a pharmacist intervention as part of a hospital ward team in patients 65 years and older with dementia or cognitive impairment were used. The study was conducted between 2012 and 2014 in the orthopedic and medicine wards in two hospitals located in Northern Sweden. Drug-related problems identified in this patient group were classified and described, and associations with different factors were investigated.

Source: Methods

Abstract: Results

Clinical pharmacists identified at least one DRP in 66% (140/212) of participants in the intervention group, for a total of 310 DRPs. Ineffective drug/inappropriate drug and unnecessary drug therapy were the most common drug-related problems. Discontinuation of drug therapy was the most common action carried out. Drug-related problems were more common among people prescribed a larger number of drugs and among people with an earlier stroke.

Source: Results

Abstract: Conclusions

Drug-related problems are common among people with dementia and cognitive impairment. Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.

Source: Conclusions
Authors’ abstract

Background

Drug-related problems, including medication errors and adverse drug events, are common among old people. Due to, for example, greater susceptibility to side effects, people with dementia are even more at risk of drug-related problems. The objectives of this study were to assess the occurrence and character of drug-related problems found among old people with dementia or cognitive impairment.

Methods

Data from a randomized controlled clinical trial exploring the effects of a pharmacist intervention as part of a hospital ward team in patients 65 years and older with dementia or cognitive impairment were used. The study was conducted between 2012 and 2014 in the orthopedic and medicine wards in two hospitals located in Northern Sweden. Drug-related problems identified in this patient group were classified and described, and associations with different factors were investigated.

Results

Clinical pharmacists identified at least one DRP in 66% (140/212) of participants in the intervention group, for a total of 310 DRPs. Ineffective drug/inappropriate drug and unnecessary drug therapy were the most common drug-related problems. Discontinuation of drug therapy was the most common action carried out. Drug-related problems were more common among people prescribed a larger number of drugs and among people with an earlier stroke.

Conclusions

Drug-related problems are common among people with dementia and cognitive impairment. Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.

Publication and source details

Original title: Drug-related problems and medication reviews among old people with dementia

Bettina Pfister; Jeanette Jonsson; Maria Gustafsson

BMC Pharmacology & Toxicology · 2017

© The Author(s). 2017https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Swedish Dementia AssociationCounty Council of VästerbottenJanne Elgqvists foundation Svenska Läkaresällskapet (SE)

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:37:46.607375+00:00

DOI: 10.1186/s40360-017-0157-2 · PMC5488493